open access

Vol 71, No 6 (2020)
Clinical vignette
Submitted: 2020-06-11
Accepted: 2020-06-20
Early publication date: 2020-09-25
Get Citation

Endoscopic ultrasound-guided ethanol ablation of insulinoma

Ewa Zalewska1, Przemysław Kłosowski1, Michał Dubowik2, Rafał Pęksa3, Krzysztof Sworczak1
DOI: 10.5603/EP.a2020.0070
·
Pubmed: 33125699
·
Endokrynol Pol 2020;71(6):585-586.
Affiliations
  1. Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk, Poland
  2. Department of Gastroenterology and Hepatology, Medical University of Gdansk, Gdansk, Poland
  3. Department of Pathology, Medical University of Gdansk, Gdansk, Poland

open access

Vol 71, No 6 (2020)
Clinical Vignette
Submitted: 2020-06-11
Accepted: 2020-06-20
Early publication date: 2020-09-25

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

insulinoma; ethanol ablation; hypoglycemia

About this article
Title

Endoscopic ultrasound-guided ethanol ablation of insulinoma

Journal

Endokrynologia Polska

Issue

Vol 71, No 6 (2020)

Article type

Clinical vignette

Pages

585-586

Early publication date

2020-09-25

Page views

426

Article views/downloads

444

DOI

10.5603/EP.a2020.0070

Pubmed

33125699

Bibliographic record

Endokrynol Pol 2020;71(6):585-586.

Keywords

insulinoma
ethanol ablation
hypoglycemia

Authors

Ewa Zalewska
Przemysław Kłosowski
Michał Dubowik
Rafał Pęksa
Krzysztof Sworczak

References (5)
  1. Buicko JL, Finnerty BM, Zhang T, et al. Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors. Ann Pancreat Cancer. 2019; 2.
  2. Kos-Kudła B, Blicharz-Dorniak J, Strzelczyk J, et al. Consensus Conference, olish Network of Neuroendocrine Tumours. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2013; 64(6): 459–479.
  3. Barthet M, Giovannini M, Lesavre N, et al. Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study. Endoscopy. 2019; 51(9): 836–842.
  4. Mele C, Brunani A, Damascelli B, et al. Non-surgical ablative therapies for inoperable benign insulinoma. J Endocrinol Invest. 2018; 41(2): 153–162.
  5. Dąbkowski K, Gajewska P, Walter K, et al. Successful EUS-guided ethanol ablation of insulinoma, four-year follow-up. Case report and literature review. Endokrynol Pol. 2017; 68(4): 472–479.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl